002287.SZ Stock Analysis
00
Avoid
Based on Eyestock quantitative analysis, 002287.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicine. The company is headquartered in Nyingchi, Xizang and currently employs 2,869 full-time employees. The company went IPO on 2009-08-28. The firm primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The firm's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The firm distributes its products within domestic market and to overseas markets.